Your browser doesn't support javascript.
loading
CX3CR1 is dysregulated in blood and brain from schizophrenia patients.
Bergon, Aurélie; Belzeaux, Raoul; Comte, Magali; Pelletier, Florence; Hervé, Mylène; Gardiner, Erin J; Beveridge, Natalie J; Liu, Bing; Carr, Vaughan; Scott, Rodney J; Kelly, Brian; Cairns, Murray J; Kumarasinghe, Nishantha; Schall, Ulrich; Blin, Olivier; Boucraut, José; Tooney, Paul A; Fakra, Eric; Ibrahim, El Chérif.
Afiliação
  • Bergon A; INSERM, TAGC UMR_S 1090, 13288 Marseille Cedex 09, France; Aix Marseille Université, TAGC UMR_S 1090, 13288 Marseille Cedex 09, France.
  • Belzeaux R; Aix Marseille Université, CNRS, CRN2M UMR 7286, 13344 Marseille Cedex 15, France; FondaMental, Fondation de Recherche et de Soins en Santé Mentale, 94000 Créteil, France; AP-HM, Hôpital Sainte Marguerite, Pôle de Psychiatrie Universitaire Solaris, 13009 Marseille, France.
  • Comte M; Aix-Marseille Université, CNRS, Institut de Neurosciences de la Timone UMR 7289, 13005 Marseille, France.
  • Pelletier F; Aix Marseille Université, CNRS, CRN2M UMR 7286, 13344 Marseille Cedex 15, France; FondaMental, Fondation de Recherche et de Soins en Santé Mentale, 94000 Créteil, France.
  • Hervé M; Aix Marseille Université, CNRS, CRN2M UMR 7286, 13344 Marseille Cedex 15, France; FondaMental, Fondation de Recherche et de Soins en Santé Mentale, 94000 Créteil, France.
  • Gardiner EJ; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Beveridge NJ; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Liu B; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; K
  • Carr V; Schizophrenia Research Institute, Darlinghurst, NSW 2010 Australia; School of Psychiatry, University of New South Wales, Randwick, NSW 2301, Australia; Department of Psychiatry, Monash University, Clayton, VIC 3168, Australia.
  • Scott RJ; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Kelly B; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Cairns MJ; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Kumarasinghe N; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Schall U; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Blin O; CIC-UPCET et Pharmacologie Clinique, Hôpital de la Timone, 13005 Marseille, France.
  • Boucraut J; Aix Marseille Université, CNRS, CRN2M UMR 7286, 13344 Marseille Cedex 15, France; FondaMental, Fondation de Recherche et de Soins en Santé Mentale, 94000 Créteil, France.
  • Tooney PA; School of Biomedical Sciences and Pharmacy and School of Medicine and Public Health, Faculty of Health, The University of Newcastle, University Drive, Callaghan, NSW 2308 Australia; Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Callaghan, NSW 2308 Australia; H
  • Fakra E; Aix-Marseille Université, CNRS, Institut de Neurosciences de la Timone UMR 7289, 13005 Marseille, France; CHU de Saint-Etienne, Pôle de Psychiatrie, 42100 Saint-Etienne, France.
  • Ibrahim EC; Aix Marseille Université, CNRS, CRN2M UMR 7286, 13344 Marseille Cedex 15, France; FondaMental, Fondation de Recherche et de Soins en Santé Mentale, 94000 Créteil, France. Electronic address: el-cherif.ibrahim@univ-amu.fr.
Schizophr Res ; 168(1-2): 434-43, 2015 10.
Article em En | MEDLINE | ID: mdl-26285829

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Encéfalo / Receptores de Quimiocinas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Encéfalo / Receptores de Quimiocinas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Ano de publicação: 2015 Tipo de documento: Article